List view / Grid view
26 October 2015 | By Victoria White
The approval was based on recently published clinical efficacy and safety data from a Phase 3 study which evaluated Yondelis versus the chemotherapy agent dacarbazine...
23 October 2015 | By Victoria White
BMS-955176 is a second-generation maturation inhibitor designed to inhibit one of the last steps of the HIV-1 viral lifecycle...
23 October 2015 | By Victoria White
Cosentyx Phase III studies have consistently demonstrated significant improvements in the signs and symptoms of ankylosing spondylitis and psoriatic arthritis...
23 October 2015 | By Victoria White
If approved by the European Commission, Imlygic would be the first in a class of novel agents known as oncolytic immunotherapies...
23 October 2015 | By HORIBA Scientific
HORIBA Scientific, global leader in Raman spectroscopy systems for over 50 years, announces the release of their new ProtectionPlus module for the acclaimed LabSpec 6 Spectroscopy Suite...
23 October 2015 | By Victoria White
The Phase III study evaluated the investigational use of Dysport for the treatment of spastic equinus foot, a condition associated with cerebral palsy in children aged 2-17...
23 October 2015 | By Victoria White
Isavuconazole will benefit from ten years of market exclusivity associated with orphan medicinal product status in the European Union...
23 October 2015 | By Victoria White
MHRA Enforcement officers seized nearly £1 million worth of unlicensed erectile dysfunction medicines from an address in Slough...
23 October 2015 | By Victoria White
GlobalData says this increase will be driven by the modest uptake of patent-protected, Clostridium difficile infection-specific antibiotics and the arrival of novel non-antibiotic approaches...
22 October 2015 | By Victoria White
Genvoya was found to be statistically non-inferior to Stribild based on percentages of patients with HIV-1 RNA levels less than 50 copies/mL...
22 October 2015 | By Victoria White
Trial startup activities are underway and MacroGenics expects to begin enrolling patients by the first quarter of 2016...
Life scientists who work with DNA, RNA and proteins can make educated decisions about sample suitability in experiments using a standalone, microvolume spectrophotometer for accurate quantitation and purity measurements to ensure downstream application success.
22 October 2015 | By Victoria White
GS-5734 was discovered as part of Gilead’s programme to screen compounds in its libraries for activity against a range of potential emerging viruses, including Ebola...
22 October 2015 | By Victoria White
The CPhI Pharma Awards recognise life sciences firms that turn inspiration into innovation, and celebrate thinkers and creators that are breaking new ground in formulation, process development, packaging, technology, and more...
22 October 2015 | By Victoria White
Under the terms of the expanded agreement, AstraZeneca and Lilly will evaluate the safety and efficacy of a range of additional combinations across the companies’ portfolios...
